In another study, administration of a fixed dose subcutaneous continuous infusion of glucagon for 4 weeks, did not improve epinephrine response to hypoglycemia in individuals with T1D and IAH (ClinicalTrials, 2023a). Here, GCG is linked to type 1 diabetes mellitus.